Register content provider
3 content providers found

Keywords: genomics  or immunology 


  • PerMedCoE

    PerMedCoE is the HPC/Exascale Centre of Excellence for Personalised Medicine in Europe.

    10 training materials
    PerMedCoE http://tess.elixir-uk.org/content_providers/permedcoe PerMedCoE is the HPC/Exascale Centre of Excellence for Personalised Medicine in Europe. /system/content_providers/images/000/000/637/original/LOGO_PerMedCoE.jpg?1636473064
  • COG-Train

    COG-Train is an international educational initiative providing open-access learning in SARS-CoV-2...

    3 training materials
    COG-Train http://tess.elixir-uk.org/content_providers/cog-train COG-Train is an international educational initiative providing open-access learning in SARS-CoV-2 genomics. It aims to facilitate an increase in global genome sequencing and analysis capacity, reduce sequencing inequality and enhance pathogen surveillance. The programme’s training courses and development are built around our core concept of partnering with international researchers, public health experts and surveillance networks and providing open-access FREE training for all. COG-Train is funded by Wellcome Trust and the Foreign, Commonwealth & Development Office and led jointly by COVID-19 Genomics UK (COG-UK) consortium and Wellcome Connecting Science (WCS). Whole Viral Genome sequencing is an essential tool to identify and track the emergence and spread of SARS-CoV-2 variants as the COVID-19 pandemic progresses. Sequence data informs public health interventions and the further development of diagnostics, therapeutics and vaccines. There is inequity of access to pathogen sequencing worldwide, and COG-Train is committed to contributing towards efforts that close this gap. By building global partnerships with sequencing networks and scientists around the world, we hope to build a truly inclusive training programme that shares the many challenges faced in sequencing efforts, as well as highlighting the numerous success stories, and facilitating knowledge sharing. Outputs include a series of massive online, open-access courses on all aspects of SARS-CoV-2 sequencing based on WCS’s successful use of the FutureLearn platform, as well as week-long intensive virtual training courses, short expert workshops and concurrent distributed Classrooms, the latter of which utilises blended training. The distributed classroom model will be used to increase reach and impact of the learning materials, with training being delivered simultaneously in multiple classrooms across many countries. The training programme includes train-the-trainer components to help further build capacity in-country, rather than rely on a one-hit train and leave model. The COG-Train educational programme builds on the COG-UK values of data sharing, open collaboration, value for money, inclusivity and the prioritisation of public health impact. /system/content_providers/images/000/000/644/original/COG-Train_Logo.png?1657104279
  • Biomedical Sciences Research Center "Alexander Fleming"

    The Biomedical Sciences Research Center "Alexander Fleming" is a non-profit research organisation...

    1 training material
    Biomedical Sciences Research Center "Alexander Fleming" http://tess.elixir-uk.org/content_providers/biomedical-sciences-research-center-alexander-fleming The Biomedical Sciences Research Center "Alexander Fleming" is a non-profit research organisation based in Vari, Athens, Greece. Since the beginning of its operations in 1998, the Center develops basic as well as translational and applied research programs at the cutting edge of modern biomedical sciences. Currently, the Center hosts 14 research groups distributed in 4 Institutes (Immunology, Molecular Oncology, Molecular Biology and Genetics, Cellular & Developmental Biology). Over the short period since its establishment, BSRC "Alexander Fleming" has gained extensive visibility in the European science arena. Fleming researchers have established transgenic animal models for rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis and these models have served as a basis for multiple collaborations with the international biopharmaceutical industry in the evaluation of novel therapeutic compounds, or as tools for collaborative R&D. The Center is equipped with state-of-the-art Core Units which include: an Expression Profiling Facility, a Flow Cytometry Facility, a Protein Chemistry Lab, a Transgenics and gene targeting Unit, and a BioIT Unit, all of which serve internal collaborations, as well as external partners in academia and industry. The Center also runs an Innovation and Enterprise Unit that facilitates the protection and exploitation of the Center’s research and technologies. Fleming operates its own Animal House, which can house up to 15,000 mice, and has its own complete mouse histopathology unit. Fleming’s Animal house (certified with ISO 9001) provides husbandry of animals and services to the biomedical research community since 2001. It covers an area of approximately 600 m2 within the Center and is equipped with highly automated systems that provide the best possible conditions for mouse reproduction and maintenance. Its main activity is the reproduction and maintenance of mice stocks either of inbred strains or genetically engineered mice, such as transgenic and knockout mouse lines, as well as chemically induced mutants developed by Fleming researchers. The Animal House has a capacity to house more than 18,000 mice and is currently the largest Mouse Unit in Greece in terms of number and variety of mice. The Facility became a full member of EMMA in 2009. Main areas of research: Functional genomics and proteomics; Molecular and cellular immunology; Animal models of human disease; Transcriptional and post-transcriptional mechanisms of gene regulation; DNA repair; Stem Cell differentiation; Epigenetics; Learning and memory; ECM biology. Fields of excellence: Molecular mechanisms of disease (inflammation, cancer, metabolic syndrome, CNS disorders). /system/content_providers/images/000/000/051/original/logo.png?1469458221